September 30, 2025 • 8:00 AM EDT ASP Isotopes Announces Purchase Order for Enriched Barium-137 from a U.S.-Based Customer
September 29, 2025 • 8:00 AM EDT ASP Isotopes Inc. Announces Changes to the Executive Management Teams of ASP Isotopes Inc. and Quantum Leap Energy LLC Effective October 2025
September 8, 2025 • 8:00 AM EDT Nuclear Power Industry Veteran Ralph Hunter Joins Board of Directors of ASP Isotopes Inc. and Board of Managers of Quantum Leap Energy LLC
August 26, 2025 • 8:00 AM EDT ASP Isotopes Inc. Hosts South African Investors in Advance of Secondary Listing on the Johannesburg Stock Exchange (JSE) and Provides Updates on its Isotope Production Plants
August 15, 2025 • 8:55 AM EDT ASP Isotopes Inc. and its Subsidiary, Quantum Leap Energy LLC, enter into a Memorandum of Understanding with Fermi America Regarding a Joint Venture to Collaborate on the Research, Development and Construction of an Advanced Nuclear Fuel Research and Production Facility at the Planned 11GW HyperGrid Campus in Carson County, Texas
August 8, 2025 • 9:00 AM EDT ASP Isotopes Inc. Announces Expected Commencement of Dual Listing on Johannesburg Stock Exchange
July 28, 2025 • 8:31 AM EDT ASP Isotopes Inc. and IsoBio, Inc. Announce Series Seed Funding of IsoBio, Inc. to Advance Innovative Antibody-Isotope Conjugates (AICsTM) For Cancer Treatment
July 25, 2025 • 8:59 AM EDT Competition Commission of South Africa Approves the Offer by ASP Isotopes Inc. for Renergen Limited
July 23, 2025 • 6:15 PM EDT ASP Isotopes Inc. Announces Pricing of $60 Million Underwritten Registered Direct Offering of Common Stock
